Identifying critical windows of susceptibility to perinatal lead exposure on child serum vaccine antibody levels
- PMID: 39894752
- PMCID: PMC12671974
- DOI: 10.1093/aje/kwaf012
Identifying critical windows of susceptibility to perinatal lead exposure on child serum vaccine antibody levels
Abstract
Mounting evidence suggests that early-life lead exposure alters immune system functions, including T-cell-dependent antibody responses to childhood immunizations. However, no studies have identified critical windows of susceptibility to lead exposure. The aim of this study was to identify perinatal critical windows of lead exposure that are associated with antibody responses to anti-MMR (measles, mumps, and rubella virus) and anti-DTP (anti-diphtheria, tetanus, and pertussis toxoids) vaccinations in Hispanic school-aged (mean ± standard deviation: 4.8 ± 0.6 years) children. Weekly lead exposure-from 16 weeks before to 14 weeks after birth-was measured in deciduous teeth from 271 children enrolled in the PROGRESS study. Serum levels of anti-MMR and anti-DTP antibodies were measured by a Luminex multiplexed microbead array immunoassay. Time-varying associations between log2-transformed dentine lead concentrations and log2-transformed antibody levels were estimated by fitting distributed lag nonlinear models. A 2-fold higher dentine lead concentration in the first 3 weeks postpartum was associated with an average -4.29% lower antitetanus level (95% CI, -8.22 to -0.20). A perinatal (1 week before to 1 week after birth) critical window of lead exposure demonstrated an average -3.44% (95% CI, -7.05 to 0.30) lower anti-diphtheria antibody level. Our study suggests that early-life lead exposure may contribute to immune dysfunction by reducing children's antibody responses to scheduled vaccinations.
Keywords: T cell; adaptive immune system; dentine; distributive lag models; immune system; immunotoxicology; pediatrics.
© The Author(s) 2025. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Conflict of interest statement
The authors declare no conflicts of interest.
References
MeSH terms
Substances
Grants and funding
- R01 ES026033/ES/NIEHS NIH HHS/United States
- R24 ES028522/ES/NIEHS NIH HHS/United States
- P30 ES023515/ES/NIEHS NIH HHS/United States
- R01 ES014930/ES/NIEHS NIH HHS/United States
- U2C ES030859/ES/NIEHS NIH HHS/United States
- R35 ES030435/ES/NIEHS NIH HHS/United States
- R01 ES034521/ES/NIEHS NIH HHS/United States
- R01 ES013744/ES/NIEHS NIH HHS/United States
- R01ES033245/NH/NIH HHS/United States
- R01ES021357/NH/NIH HHS/United States
- R24ES028522/NH/NIH HHS/United States
- R01ES013744/NH/NIH HHS/United States
- R01ES014930/NH/NIH HHS/United States
- R01ES026033/NH/NIH HHS/United States
- U2CES030859/NH/NIH HHS/United States
- R35ES030435/NH/NIH HHS/United States
- P30ES001247/NH/NIH HHS/United States
- P30ES023515/NH/NIH HHS/United States
- R01ES034521/NH/NIH HHS/United States
- R01ES032242/NH/NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
